RxDoctor Payments Data

Gabriel Gambardella

Foot & Ankle Surgery · Bloomfield, CTNPI 1447577309

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 47 manufacturers reported payments, led by Gramercy Extremity Orthopedics LLC at 47.5% of the total. Reporting peaked in 2023 at $28,829 and has fallen 81.7% since, to $5,281 in 2025. Among foot & ankle surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$98,958in general payments, 2019–2025

Across 311 payments — averaging $318.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gramercy Extremity Orthopedics LLC$47K
  • Smith+Nephew$20K
  • Vilex LLC$12K
  • Bioventus LLC$5K
  • Celularity Inc.$5K
  • Zimmer Biomet$3K
  • plus $8K from 41 others

What the payments were for

  • Royalty or licence$7,4408%
  • Consulting fees$45,65846%
  • Speaking & faculty fees$28,51629%
  • Travel & lodging$4,1914%
  • Food & beverage$11,39612%
  • Education$1,7572%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$98,958 in reported general payments places this provider in the 95th percentile of 89 foot & ankle surgery providers in Connecticut.

See all foot & ankle surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$124,906
Medicare patients
257
Services billed
1,541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naftifine Hcl13$4,527
Ketoconazole19$552
Cephalexin14$507
Doxycycline Monohydrate32$377
Methylprednisolone31$261
Ammonium Lactate11$216
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$186
Silver Sulfadiazine14$103
Gabapentin12$102
Meloxicam20$19

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Bloomfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →